Synthesis and biological evaluation of aromatic enones related to curcumin

Bioorganic and Medicinal Chemistry

Volumn 13, Issue 12, 2005, Pages 4007-4013

  Robinson, Thomas Philip ^b   Hubbard IV, Richard B ^b   Ehlers, Tedman J ^b   Arbiser, Jack L ^c   Goldsmith, David J ^d   Bowen, J Phillip ^a  

^a UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d EMORY UNIVERSITY   (United States)

Author keywords

Angiogenesis; Chalcone; Curcumin; Enone

Indexed keywords

1 (1 NAPHTHYL) 3 (2 NAPHTHYL)PROPENONE; 1 (1 NAPHTHYL) 3 PHENYLPROPENONE; 1 PHENYL 3 (2 PYRROLYL)PROPENONE; 1 PHENYL 3 (3 PYRIDYL)PROPENONE; 1,3 BIS(2 PYRIDYL)PROPENONE; 2 (2,6 DICHLOROBENZYLIDENE)TETRALONE; 2',6' DIMETHOXYCHALCONE; 2,2',3,3',4,4',5,5',6,6' DECAFLUOROCHALCONE; ANGIOGENESIS INHIBITOR; CURCUMIN; KETONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL PROLIFERATION; COMMERCIAL PHENOMENA; CONTROLLED STUDY; DRUG SCREENING; DRUG SYNTHESIS; ENDOTHELIUM CELL; IN VITRO STUDY; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; CELLS, CULTURED; CURCUMIN; DRUG SCREENING ASSAYS, ANTITUMOR; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; MICE; MICE, INBRED C57BL; STRUCTURE-ACTIVITY RELATIONSHIP;

CURCUMA LONGA;

EID: 19444363120     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2005.03.054     Document Type: Article

References (19)

1. H.P. Ammon, and M. Wahl Planta Med. 57 1991 1
2. G.D. Stoner, and H. Mukhtar J. Cell. Biochem. Suppl. 22 1995 169
3. O.P. Sharma Biochem. Pharmacol. 25 1976 1811
4. S. Toda, T. Miyase, H. Arichi, H. Tanizawa, and Y. Takiyano Chem. Pharm. 33 1985 1725
5. R.C. Srimal, and B.N. Dhawan J. Pharm. Pharmacol. 25 1973 447
6. R.R. Satoskar, S.J. Shah, and S.G. Shenoy Int. J. Clin. Pharmacol. Ther. Toxicol. 24 1986 651
7. A. Mazumder, K. Raghavan, J. Weinstein, K.W. Kohn, and Y. Pommer Biochem. Pharmacol. 49 1995 1165
8. D. Eigner, and D. Scholz J. Ethnopharmacol. 67 1999 1
9. M.T. Huang, Y.R. Lou, W. Ma, H.L. Newmark, K.R. Reuhl, and A.R. Conney Cancer Res. 54 1994 5841
10. C.V. Rao, A. Rivenson, B. Simi, and B.S. Reddy Cancer Res. 55 1995 259
11. A.H. Conney, T. Lysz, T. Ferraro, T.F. Abidi, P.S. Manchand, J.D. Laskin, and M.T. Huang Adv. Enzyme Regul. 31 1991 385
12. M.T. Huang, W. Ma, Y.P. Lu, R.L. Chang, C. Fisher, P.S. Manchand, H.L. Newmark, and A.H. Conney Carcinogenesis 16 1995 2493
13. M.T. Huang, E.E. Deschner, H.L. Newmark, Z.Y. Wang, T.A. Ferraro, and A.H. Conney Cancer Lett. 64 1992 117
14. J.L. Arbiser, N. Klauber, R. Rohan, R. van Leeuwen, M.T. Huang, C. Fisher, E. Flynn, and H.R. Byers Mol. Med. 4 1998 376
15. T.P. Robinson, T. Ehlers, R.B. Hubbard, X.H. Bai, J.L. Arbiser, D.J. Goldsmith, and J.P. Bowen Bioorg. Med. Chem. Lett. 13 2003 115
16. M.S. Furness, T.P. Robinson, T. Ehlers, R.B. Hubbard IV, J.L. Arbiser, D.J. Goldsmith, and J.P. Bowen Curr. Pharm. Des. 11 2005 357
17. Bowen, J. P.; Robinson, T. P.; Ehlers, T.; Goldsmith, D.; Arbiser, J. Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states. PCT Int. Appl. WO0146110, June 28, 2001
18. J.S. Shim, J.H. Kim, H.Y. Cho, Y.N. Yum, S.H. Kim, and H.J. Park Chem. Biol. 10 2003 695
19. J.L. Arbiser, M.A. Moses, C.A. Fernandez, N. Ghiso, Y. Cao, N. Klauber, D. Frank, M. Brownlee, E. Flynn, S. Parangi, H.R. Byers, and J. Folkman Proc. Natl. Acad. Sci. U.S.A. 94 1997 861